| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Metabolic system |
代謝系統(tǒng) |
|
詳細(xì)
|
| Screening model of gastrointestinal motility inhibitors |
胃腸動力抑制劑篩選模型 |
|
詳細(xì)
|
| Myocardial injury protective agent screening model |
心肌損傷保護(hù)劑篩選模型 |
|
詳細(xì)
|
| Screening model of renal protective agents |
腎功能保護(hù)劑篩選模型 |
|
詳細(xì)
|
| Reproductive toxicity and reproductive ability evaluation; Gonadal growth evaluation; Histological sections of gonads; |
生殖毒性生殖能力評價;性腺生長評價;性腺病理組織切片; |
|
詳細(xì)
|
| Gastrointestinal peristalsis function (autonomic nerve). |
胃腸蠕動功能（植物神經(jīng)）。 |
|
詳細(xì)
|
| inflammatory reaction |
炎癥反應(yīng) |
|
詳細(xì)
|
| Intestinal morphology; Intestinal peristalsis requires motor function. |
腸道形態(tài)學(xué);腸蠕需動功能。 |
|
詳細(xì)
|
| Carry out appropriate toxicity tests with experimental animals |
用實驗動物進(jìn)行適當(dāng)?shù)亩拘栽囼?/td>
| |
詳細(xì)
|
| Genetically modified animal model |
遺傳修飾動物模型 |
|
詳細(xì)
|
| Apoptosis inhibitor screening model |
凋亡抑制劑篩選模型 |
|
詳細(xì)
|
| Fat metabolism model |
脂肪代謝模型 |
|
詳細(xì)
|
| Erythrocyte thrombosis model |
紅細(xì)胞性血栓模型 |
|
詳細(xì)
|
| Mouse bradycardia model |
小鼠心動過緩模型 |
|
詳細(xì)
|
| Incidence of developmental toxicity and teratogenicity (brain, jaw, eye, kidney, intestine, trunk / tail / spinal cord / somite, body coloring, circulatory system, body edema, bleeding) |
發(fā)育毒性與致畸性（腦、下顎、眼、腎臟、腸道、軀干/尾/脊髓/體節(jié)、身體著色、循環(huán)系統(tǒng)、身體水腫、出血）毒性發(fā)生率 |
|
詳細(xì)
|
| Behavior (touch response, movement influence, light and dark influence); |
行為學(xué)（觸碰反應(yīng)、運動影響、光暗影響）; |
|
詳細(xì)
|
| Behavior |
行為學(xué) |
|
詳細(xì)
|
| Anaphylactic reaction |
類過敏反應(yīng) |
|
詳細(xì)
|
| Animal model of depression |
抑郁動物模型 |
|
詳細(xì)
|
| neurotoxicity |
神經(jīng)毒性 |
|
詳細(xì)
|
| Immunotoxicity |
免疫毒性 |
|
詳細(xì)
|
| Preclinical drug experiment preclinical research (outsourcing entrusted experiment) |
藥物臨床前實驗 臨床前研究（外包委托實驗） |
|
詳細(xì)
|
| Efficacy evaluation model of drug efficacy evaluation system |
藥物功效評價 系統(tǒng) 功效評價模型 |
|
詳細(xì)
|
| Mitochondrial function |
線粒體功能 |
|
詳細(xì)
|
| Protective model of vascular endothelial injury |
血管內(nèi)皮損傷保護(hù)模型 |
|
詳細(xì)
|
| Promoting tissue regeneration / wound healing |
促組織再生作用/傷口愈合 |
|
詳細(xì)
|
| Embryotoxicity (OECD standard) |
胚胎毒性（OECD標(biāo)準(zhǔn)） |
|
詳細(xì)
|
| Degree of liver degeneration; Yolk sac size. |
肝變性程度;卵黃囊大小。 |
|
詳細(xì)
|
| Osteotoxicity |
骨毒性 |
|
詳細(xì)
|
| Phenotypic observation |
表型觀察 |
|
詳細(xì)
|
| Induction model of high sugar and high fat diet |
高糖高脂飲食誘導(dǎo)模型 |
|
詳細(xì)
|
| Screening model of antialcoholic agents |
解酒劑篩選模型 |
|
詳細(xì)
|
| Screening model of angiogenesis promoters |
血管再生促進(jìn)劑篩選模型 |
|
詳細(xì)
|
| Cytochrome P450 analysis |
細(xì)胞色素P450分析 |
|
詳細(xì)
|
| Cartilage injury model |
軟骨損傷模型 |
|
詳細(xì)
|
| apoptotic cell |
凋亡細(xì)胞 |
|
詳細(xì)
|
| The incidence of renal capsule edema;. |
腎包膜水腫發(fā)生率;。 |
|
詳細(xì)
|
| Ocular toxicity |
眼毒性 |
|
詳細(xì)
|
| Mortality; Evaluation of median lethal concentration (LC50). |
死亡率;半數(shù)致死濃度（LC50）評價。 |
|
詳細(xì)
|
| Screening model of P-glycoprotein inhibitors |
P-糖蛋白抑制劑篩選模型 |
|
詳細(xì)
|
| Screening model of energy metabolism regulator |
能量代謝調(diào)節(jié)劑篩選模型 |
|
詳細(xì)
|
| Induced qi stagnation and blood stasis thrombosis model |
誘導(dǎo)氣滯血瘀型血栓模型 |
|
詳細(xì)
|
| Liver kidney model |
肝腎模型 |
|
詳細(xì)
|
| Cardiovascular toxicity heart rate; Heart rhythm; The incidence of pericardial edema; Incidence of bleeding; Incidence of changes in blood flow velocity; Incidence of thrombosis |
心血管毒性心率;心律;心包水腫發(fā)生率;出血發(fā)生率;血流速度變化的發(fā)生率;血栓發(fā)生率 |
|
詳細(xì)
|
| Fluorescence signal intensity of apoptotic cells in central nervous system; |
中樞神經(jīng)凋亡細(xì)胞熒光信號強度; |
|
詳細(xì)
|
| Carcinogenicity (mice) |
致癌性（小鼠） |
|
詳細(xì)
|
| Tryptase expression level (OD value); Anaphylactic reaction test. |
Tryptase表達(dá)水平（OD值）;類過敏反應(yīng)檢測。 |
|
詳細(xì)
|
| Animal experiment of depression |
抑郁動物實驗 |
|
詳細(xì)
|
| Preclinical evaluation of cardiac drugs |
心臟藥物臨床前評價 |
|
詳細(xì)
|
| Anti angiogenesis model |
抗血管形成模型 |
|
詳細(xì)
|
| Cardio cerebrovascular |
心腦血管 |
|
詳細(xì)
|
| PM2. 5. Screening model of drainage promoters |
PM2.5促排劑篩選模型 |
|
詳細(xì)
|
| Screening model of bone development promoters |
骨骼發(fā)育促進(jìn)劑篩選模型 |
|
詳細(xì)
|
| The incidence of egg coagulation; No heart rate; Hatching rate; The incidence of no somite formation; Incidence of tail non separation; |
卵凝結(jié)發(fā)生率;無心跳發(fā)生率;孵化率;體節(jié)未形成發(fā)生率;尾部未分離發(fā)生率; |
|
詳細(xì)
|
| Nephrotoxicity |
腎毒性 |
|
詳細(xì)
|
| Bone mineral density (fluorescence signal intensity); Number of vertebrae. |
骨密度（熒光信號強度）;脊椎骨數(shù)量。 |
|
詳細(xì)
|
| Median lethal concentration |
半數(shù)致死濃度 |
|
詳細(xì)
|
| Should we experiment with animals |
應(yīng)該用動物做實驗嗎 |
|
詳細(xì)
|
| Skin irritation; Muscle texture; Quantification of skin apoptotic cells; Skin pigment changes. |
皮膚刺激;肌肉紋理;皮膚凋亡細(xì)胞定量;皮膚色素變化。 |
|
詳細(xì)
|
| Safety evaluation |
安全性評價 |
|
詳細(xì)
|
| Preclinical evaluation of antiviral research and development |
抗病毒研發(fā)臨床前評價 |
|
詳細(xì)
|
| Uric acid model |
尿酸模型 |
|
詳細(xì)
|
| Intestinal digestive function |
腸道消化功能 |
|
詳細(xì)
|
| Skeletal muscle |
骨骼肌肉 |
|
詳細(xì)
|
| Screening model of therapeutic agents for osteoporosis |
骨質(zhì)疏松癥治療劑篩選模型 |
|
詳細(xì)
|
| Fluorescence signal intensity of apoptotic cells (AO staining, TUNEL staining) |
凋亡細(xì)胞熒光信號強度（AO染色、TUNEL染色） |
|
詳細(xì)
|
| Audiotoxicity |
聽毒性 |
|
詳細(xì)
|
| Eye size; Ocular apoptotic cells; Ocular vascular area; Ocular histopathology. |
眼睛大小;眼部凋亡細(xì)胞;眼部血管面積;眼組織病理學(xué)。 |
|
詳細(xì)
|
| Genotoxicity |
基因毒性 |
|
詳細(xì)
|
| Induction model of caspase activity |
對Caspase活性的誘導(dǎo)作用模型 |
|
詳細(xì)
|
| Pharmacodynamic evaluation model of slimming drugs |
減肥藥藥效評價模型 |
|
詳細(xì)
|
| Drug screening model for the treatment of heart failure |
心衰治療藥物篩選模型 |
|
詳細(xì)
|
| Screening model of hepatoprotective drugs |
保肝藥篩選模型 |
|
詳細(xì)
|
| Number of hematotoxic neutrophils; Number of macrophages; Number of red blood cells (signal intensity); Blood flow. |
血液毒性中性粒細(xì)胞數(shù)量;巨噬細(xì)胞數(shù)量;紅細(xì)胞數(shù)量（信號強度）;血流量。 |
|
詳細(xì)
|
| Peripheral motor nerve length; Incidence of brain degeneration; |
周圍運動神經(jīng)長度;腦變性發(fā)生率; |
|
詳細(xì)
|
| Macrophage function |
巨噬細(xì)胞功能 |
|
詳細(xì)
|
| Gastrointestinal toxicity |
胃腸道毒性 |
|
詳細(xì)
|
| Why do experiments with animals |
用動物做實驗的原因 |
|
詳細(xì)
|
| Genetic engineering animal model |
遺傳工程動物模型 |
|
詳細(xì)
|
| mycoalert mycoplasma detection kit |
支原體檢測試劑盒 |
|
詳細(xì)
|
| Preclinical spinal cord injury experiment |
臨床前脊髓損傷實驗 |
|
詳細(xì)
|
| Angiogenesis inhibitor screening |
血管形成抑制劑篩選 |
|
詳細(xì)
|
| Hypolipidemic model |
降血脂模型 |
|
詳細(xì)
|
| Platelet aggregation thrombosis model |
血小板聚集性血栓模型 |
|
詳細(xì)
|
| Oxygen free radical (ROS) scavenger screening model |
氧自由基（ROs）清除劑篩選模型 |
|
詳細(xì)
|
| Incidence of acute toxicity (brain, jaw, eye, kidney, intestine, trunk / tail / spinal cord / somite, body coloring, circulatory system, body edema, bleeding) |
急性毒性（腦、下顎、眼、腎臟、腸道、軀干/尾/脊髓/體節(jié)、身體著色、循環(huán)系統(tǒng)、身體水腫、出血）毒性發(fā)生率 |
|
詳細(xì)
|
| Vitellogenin (VTG) content detection; The expression of genes related to hypothalamic pituitary gonadal axis was detected. |
卵黃蛋白原（VTG）含量檢測;下丘腦-垂體-性腺 軸線相關(guān)基因表達(dá)量檢測。 |
|
詳細(xì)
|
| Behavioral toxicity |
行為毒性 |
|
詳細(xì)
|
| Number of neutrophils; Expression level of inflammatory factors. |
中性粒細(xì)胞數(shù)量;炎癥因子表達(dá)水平。 |
|
詳細(xì)
|
| Factors affecting animal models |
影響動物模型的因素 |
|
詳細(xì)
|
| Drug evaluation and testing items (outsourcing entrusted experiment) |
藥物評價檢測項目（外包委托實驗） |
|
詳細(xì)
|
| Preclinical evaluation of reproductive toxicity |
生殖毒臨床前評價 |
|
詳細(xì)
|
| Spleen yang deficiency model |
脾陽虛模型 |
|
詳細(xì)
|
| Intestinal mucus secretion function |
腸道粘液分泌功能 |
|
詳細(xì)
|
| Analgesic drug screening |
鎮(zhèn)痛藥物篩選 |
|
詳細(xì)
|
| Drug safety evaluation model index |
藥物安全性評價 評價模型 指標(biāo) |
|
詳細(xì)
|
| Hepatotoxicity (juvenile fish) |
肝毒性（幼魚） |
|
詳細(xì)
|
| Fluorescence signal intensity of hair cells |
毛細(xì)胞熒光信號強度 |
|
詳細(xì)
|
| Skin toxicity |
皮膚毒性 |
|
詳細(xì)
|
| Comet experiment; Genotoxicity evaluation. |
慧星實驗;基因毒性評價。 |
|
詳細(xì)
|